Latest Market Growth News

Telix Pharmaceuticals showcased its global theranostic radiopharmaceutical portfolio, highlighting FDA approvals, clinical progress, and a robust commercial expansion plan at its 2025 Investor Day.

QuickFee Limited has launched a A$1.5 million capital raising to fund expansion of its loan books in the US and Australia, following a quarter of record revenue and positive earnings before tax. The fintech also completed a major refinancing and revised its earnings guidance due to a credit impairment provision.

Western Yilgarn NL has secured the Cardea 3 Bauxite Project in Western Australia's Darling Range, adding a significant high-grade bauxite asset near its Julimar Project. Historical drilling confirms strong alumina grades and strategic infrastructure access.

Cardiex Limited has gained Therapeutic Goods Administration approval for its CONNEQT Pulse device, paving the way for commercial expansion in Australia alongside its established US presence.

Smartpay has reported an 8.5% rise in consolidated revenue for FY2025, driven by growth in Australia and a bold entry into New Zealand’s acquiring market. However, investments in technology and market expansion have weighed on EBITDA.

Streamplay Studio Limited has inked an exclusive agreement to bring its cloud gaming service to Sri Lanka’s largest mobile network, Dialog Axiata, targeting over 19 million subscribers. This expansion follows its recent successful launch in the UAE, positioning Streamplay for growth in emerging mobile-first markets.

Superloop has reached a significant milestone under its exclusive contract with Origin Energy, surpassing 200,000 broadband subscribers on its network. This achievement highlights the growing demand for wholesale internet services in Australia.

Life360 has reported a landmark first quarter in 2025, with soaring user engagement and robust revenue growth that underscore its resilience in a cautious consumer market.

Zip Co Limited reported robust April trading with over 40% year-on-year growth in US total transaction value, underpinning a strong profitability turnaround and reaffirming its FY25 cash EBTDA guidance of at least $153 million.

XPON Technologies Group has acquired Alpha Digital for $1.72 million upfront plus performance earn-ins, immediately adding $4 million in recurring revenue and fast-tracking its path to profitability.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Zoono Group Limited reports strong progress in its shelf-life extension technology trials across multiple continents, with successful UK supermarket trials paving the way for a national roll-out in FY26. Despite a quarterly operating cash outflow, the company expects improved sales and sufficient funding to meet its near-term objectives.